Oncology - Oncology Xagena

Oncology

News

Drugs

Xagena Medicine

Xagena.net

Pregnant women have worse clinical outcomes after thyroid and parathyroid surgery

Pazopanib stops the growth of aggressive thyroid cancer

Improved brain tumor survival by reducing edema with angiogenesis inhibitor Cediranib

Zactima in combination with chemotherapy for non-small cell lung cancer shows no survival advantage

Levonorgestrel-releasing intrauterine system Mirena prevents the development of endometrial polyps in women taking Nolvadex

Trastuzumab for breast cancer can convert HER2 positive to HER 2 negative status

Lower cardiac effects with dose-dense chemotherapy in breast cancer

Aromatase inhibitors can prevent breast cancer better than Tamoxifen in postmenopausal women

Anticancer drugs Femara, Arimidex, Aromasin aren't the only cause of bone loss in breast cancer survivors

The response to IGF-I in mammary carcinoma can predict poor outcome

Femara long after stopping Tamoxifen can still offer preventive benefits in breast tumor

Glivec works in metastatic melanoma with KIT mutations

Increased survival with personalized treatment for kidney cancer

Renal cell carcinoma: Afinitor after treatment with VEGF-targeted therapies

Activation of LYN kinase is linked to resistance to Glivec in chronic myelogenous leukaemia

Cediranib in recurrent glioblastoma treatment

Bevacizumab with chemoradiation therapy in rectal cancer

Cancer-related anemia: caution is recommended in using erythropoiesis-stimulating agents

Increased number of kidney cancer patients diagnosed at earliest stage

Everolimus delays cancer progression in patients with metastatic kidney cancer

Hypertension caused by Sorafenib in patients with cancer

Better progression-free survival with Afinitor in patients with metastatic kidney cancer

New biomarkers can predict response to treatments for various type of cancer

Colorectal cancer patients with a mutation in the BRAF gene do not respond to anti-EGFR therapy

New study investigates the genetic changes involved in lung adenocarcinoma

Nexavar improves outcomes among older patients with renal carcinoma

Metastatic melanoma with KIT mutations responds to Imatinib

Kidney cancer: personalized treatment increases patient survival

Everolimus in metastatic renal cell carcinoma after treatment with VEGF-targeted therapies

Breast tumor: Femara treatment beginning long after stopping Nolvadex still offers preventive benefits

Next Pages 1 [2] 3 4 5 6 7 8 9 10 »

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions